Respreeza® Self-administration and Learning Program (AmAREtTI Study)
NCT04262284
·
clinicaltrials.gov ↗
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Alpha-1 Antitrypsin Deficiency
Sponsor
CSL Behring